Tu1833 SAFETY PROFILES OF RISANKINUMAB, USTEKINUMBA, AND VEDOLIZUMAB IN PATIENTS WITH FIBROSTENOTIC CROHN'S DISEASE: A POPULATION-BASED COHORT STUDYKevin Ma, Harland S. Winter, Pin-Chia Huang et al.|Gastroenterology|2024Cited by 0